Invention Grant
- Patent Title: Hydrates of erlotinib hydrochloride
- Patent Title (中): 盐酸埃罗替尼的水合物
-
Application No.: US11923957Application Date: 2007-10-25
-
Publication No.: US08372856B2Publication Date: 2013-02-12
- Inventor: Raymond J. H. Westheim
- Applicant: Raymond J. H. Westheim
- Applicant Address: NL Nijmegen
- Assignee: Synthon BV
- Current Assignee: Synthon BV
- Current Assignee Address: NL Nijmegen
- Agent Mark R. Buscher
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/517
Abstract:
Erlotinib hydrochloride hydrate is formed from an aqueous solution and is useful as a pharmaceutical and as a purification intermediate.
Public/Granted literature
- US20080167327A1 HYDRATES OF ERLOTINIB HYDROCHLORIDE Public/Granted day:2008-07-10
Information query
IPC分类:
